Eton Pharmaceuticals, Inc. ETON Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s operating lease ROU assets?
- Eton Pharmaceuticals, Inc. (ETON) reported operating lease ROU assets of $301K in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s operating lease ROU assets changed year-over-year?
- Eton Pharmaceuticals, Inc.'s operating lease ROU assets increased by 90.5% year-over-year, from $158K to $301K.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s operating lease ROU assets has grown at a 9.7% compound annual growth rate (CAGR), from $195K to $310K.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.